Chemoinformaics analysis of MARSTENACIGENIN A
| Molecular Weight | 498.66 | nRot | 4 |
| Heavy Atom Molecular Weight | 456.324 | nRig | 28 |
| Exact Molecular Weight | 498.298 | nRing | 5 |
| Solubility: LogS | -3.924 | nHRing | 0 |
| Solubility: LogP | 2.44 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 6 | APOL | 82.9173 |
| nHD | 5 | BPOL | 43.0027 |
| QED | 0.407 |
| Synth | 5.015 |
| Natural Product Likeliness | 2.233 |
| NR-PPAR-gamma | 0.578 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.987 |
| Pgp-sub | 0.046 |
| HIA | 0.471 |
| CACO-2 | -4.969 |
| MDCK | 0.0000191 |
| BBB | 0.992 |
| PPB | 0.915884 |
| VDSS | 1.333 |
| FU | 0.0406326 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.827 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.78 |
| CYP2c9-inh | 0.064 |
| CYP2c9-sub | 0.207 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.219 |
| CYP3a4-inh | 0.219 |
| CYP3a4-sub | 0.587 |
| CL | 7.398 |
| T12 | 0.079 |
| hERG | 0.21 |
| Ames | 0.051 |
| ROA | 0.198 |
| SkinSen | 0.856 |
| Carcinogencity | 0.165 |
| EI | 0.009 |
| Respiratory | 0.967 |
| NR-Aromatase | 0.935 |
| Antiviral | Yes |
| Prediction | 0.841024 |